Webcast: The COVID-19 Vaccine, Mutations and Implications on Reopening< 1 min read
In the latest episode of Fortunato & Friends, Exelon Chief Economist Ed Fortunato interviews returning guest Dr. Wilbur H. Chen, a professor of medicine at the University of Maryland School of Medicine, director of the University of the Maryland, Baltimore, Travel Medicine Practice, and chief of the Adult Clinical Studies section at the Center for Vaccine Development and Global Health.
Dr. Chen shares his knowledge about the many COVID-19 vaccines available today, the mutations being talked about in the news, and what he thinks it will take to reopen society. Additionally, Constellation’s Commodities Management Group member, Keith Poli, moderated the webcast and offered his insights.
The three speakers deliberated on the following questions (and more):
- Do you think we will be able to meet or beat 100 million vaccination in 100 days goal?
- Is there a risk the mutations make the vaccine less effective?
- Is it common for a virus to mutate as quickly as COVID-19 did?
- Once a person is fully vaccinated, can they still spread a COVID-19 virus to others?
- What is the difference between the Pfizer and Moderna vaccines, and the Johnson & Johnson vaccine?
- What level of vaccination percentage will be required to remove the imposed restrictions for COVID-19?
Listen to the full webcast below to hear expert insights by visiting our webinar resources page.
Every month, Fortunato & Friends, a live webcast interview, will feature a special guest to discuss topics driving the economy and energy markets. Register for our next Fortunato & Friends webcast.